Cargando…

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis

Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and severe rheumatoid arthritis (RA). The interindividual response to ABA therapy is very variable in these patients. The objective of our study was therefore to investigate the role of polymorphisms of the CTLA-4,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquez Pete, Noelia, Maldonado Montoro, María del Mar, Pérez Ramírez, Cristina, Sánchez Martín, Almudena, Martínez de la Plata, Juan Enrique, Martínez Martínez, Fernando, Caliz Caliz, Rafael, Daddaoua, Abdelali, Ramírez Tortosa, María del Carmen, Jiménez Morales, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711575/ https://www.ncbi.nlm.nih.gov/pubmed/33187286 http://dx.doi.org/10.3390/jpm10040220

Ejemplares similares

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis
por: Márquez Pete, Noelia, et al.
Publicado: (2021)

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation
por: Kennedy, Alan, et al.
Publicado: (2022)

Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
por: Pinto, Bruna F., et al.
Publicado: (2022)

Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?
por: Ville, Simon, et al.
Publicado: (2015)

By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1
por: Kleinpeter, Patricia, et al.
Publicado: (2019)

The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
por: Liu, Weixi, et al.
Publicado: (2021)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish
por: Lu, Tao-Zhen, et al.
Publicado: (2022)

Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival
por: Tian, Min, et al.
Publicado: (2013)

Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria
por: Isom, Robert, et al.
Publicado: (2019)

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
por: Sato, Takashi, et al.
Publicado: (2022)

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
por: Julià, Antonio, et al.
Publicado: (2021)

Immune suppression in cynomolgus monkeys by XPro9523: An improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn
por: Bernett, Matthew J., et al.
Publicado: (2013)

A Standardized Extract of Lentinula edodes Cultured Mycelium Inhibits Pseudomonas aeruginosa Infectivity Mechanisms
por: Tena-Garitaonaindia, Mireia, et al.
Publicado: (2022)

Corrigendum: A standardized extract of Lentinula edodes cultured mycelium inhibits Pseudomonas aeruginosa infectivity mechanisms
por: Tena-Garitaonaindia, Mireia, et al.
Publicado: (2023)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
por: Liu, Po-Chun, et al.
Publicado: (2020)

Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma
por: Chang, Cheng-Shyong, et al.
Publicado: (2007)

Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis
por: Nolan, Anna, et al.
Publicado: (2009)

In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET
por: Taddio, Marco F., et al.
Publicado: (2020)

Interferon Gamma Induces the Increase of Cell-Surface Markers (CD80/86, CD83 and MHC-II) in Splenocytes From Atlantic Salmon
por: Morales-Lange, Byron, et al.
Publicado: (2021)

Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists
por: Poirier, Nicolas, et al.
Publicado: (2012)

Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis
por: Meletta, Romana, et al.
Publicado: (2016)

Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis
por: HUANG, YANLAN, et al.
Publicado: (2020)

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
por: Ikeda, Hideki, et al.
Publicado: (2023)

Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency
por: Yang, Lu, et al.
Publicado: (2020)

Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68(+) Cells during Chronic HBV Infection
por: Said, Elias A., et al.
Publicado: (2016)

Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
por: Watanabe, M., et al.
Publicado: (2018)

CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-Cells
por: Lim, Tong Seng, et al.
Publicado: (2012)

Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
por: Trzupek, Dominik, et al.
Publicado: (2020)

Diabetes-Mediated Toxicity Resulted in the Expression of CD80 and CD86 on Neutrophils after Delayed Wound Healing in Male Rats
por: Ebaid, Hossam, et al.
Publicado: (2020)

Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4
Publicado: (1995)

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
por: Halliday, Neil, et al.
Publicado: (2020)

Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016)

Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras
por: Park, Ga Bin, et al.
Publicado: (2011)

Expression of Peripheral Blood DCs CD86, CD80, and Th1/Th2 in Sepsis Patients and Their Value on Survival Prediction
por: Du, Ke, et al.
Publicado: (2022)

CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics
por: van der Merwe, P. Anton, et al.
Publicado: (1997)

Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4(+) T Cells Independent of the PD-1 Receptor
por: Shin, Tahiro, et al.
Publicado: (2003)

Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway as Survival Biomarkers in Colorectal Cancer
por: Pérez-Durán, Carmen, et al.
Publicado: (2023)

CD80(+) and CD86(+) B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
por: Menezes, Soraya Maria, et al.
Publicado: (2014)

Dominant Role of CD80–CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells
por: Chevrier, Stéphane, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_579achju03ia423h8q6fkv1fif